Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,693 | 46 | 96.1% |
| Gift | $53.32 | 1 | 3.0% |
| Entertainment | $15.09 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $621.21 | 16 | $0 (2020) |
| TELA Bio, Inc. | $285.65 | 6 | $0 (2024) |
| Allergan Inc. | $220.60 | 5 | $0 (2018) |
| Mallinckrodt LLC | $201.28 | 3 | $0 (2018) |
| Smith+Nephew, Inc. | $93.18 | 2 | $0 (2020) |
| ACELL, INC. | $63.07 | 3 | $0 (2020) |
| Braintree Laboratories, Inc. | $53.32 | 1 | $0 (2019) |
| Dilon Technologies, Inc. | $34.78 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $27.59 | 2 | $0 (2018) |
| BAXTER HEALTHCARE | $27.57 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.42 | 5 | TELA Bio, Inc. ($47.39) |
| 2023 | $33.90 | 2 | TELA Bio, Inc. ($17.18) |
| 2021 | $19.69 | 1 | KCI USA, Inc. ($19.69) |
| 2020 | $239.51 | 7 | Merck Sharp & Dohme Corporation ($141.25) |
| 2019 | $364.43 | 8 | Merck Sharp & Dohme Corporation ($138.05) |
| 2018 | $408.20 | 13 | Merck Sharp & Dohme Corporation ($214.49) |
| 2017 | $592.52 | 12 | Mallinckrodt LLC ($186.14) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Surgical Mesh | ||||||
| 05/13/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Surgical Mesh | ||||||
| 04/15/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Surgical Mesh | ||||||
| 03/14/2024 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 02/28/2024 | Solventum Corporation | PREVENA (Device), V.A.C. VERAFLO | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 12/13/2023 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Surgical Mesh | ||||||
| 06/21/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Urology | ||||||
| 06/19/2021 | KCI USA, Inc. | PREVENA RESTOR BELLA-FORM (Device), V.A.C. VERAFLO | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 10/20/2020 | BAXTER HEALTHCARE | SEPRAFILM (Device) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Surgical Care | ||||||
| 09/08/2020 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2020 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $24.79 | General |
| 03/16/2020 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $27.27 | General |
| 03/10/2020 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2020 | Merck Sharp & Dohme Corporation | BRIDION (Drug) | Food and Beverage | In-kind items and services | $106.18 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2020 | Smith+Nephew, Inc. | PICO7 (Device) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 10/14/2019 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Food and Beverage | In-kind items and services | $107.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/10/2019 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2019 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | In-kind items and services | $53.32 | General |
| Category: GI COLON PREP | ||||||
| 03/25/2019 | CSL Behring | Kcentra (Biological) | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 03/22/2019 | DAVOL INC. | PROGEL (Device) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: INTERVENTIONAL | ||||||
| 02/20/2019 | TELA Bio, Inc. | Ovitex (Device) | Food and Beverage | In-kind items and services | $124.87 | General |
| Category: Surgical Mesh | ||||||
| 01/18/2019 | Osiris Therapeutics Inc. | Stravix (Biological), Grafix, GrafixPL | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Other Advanced Wound Management | ||||||
| 10/25/2018 | Allergan Inc. | STRATTICE (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 09/21/2018 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 347 | 358 | $173,456 | $42,338 |
| 2022 | 10 | 402 | 407 | $210,610 | $50,986 |
| 2021 | 11 | 499 | 523 | $253,570 | $62,906 |
| 2020 | 11 | 489 | 525 | $235,935 | $56,080 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 65 | 65 | $62,530 | $14,006 | 22.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 68 | 68 | $46,240 | $12,624 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $19,215 | $4,790 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 54 | $11,340 | $3,443 | 30.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $12,240 | $3,165 | 25.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 52 | $6,552 | $2,129 | 32.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $11,235 | $1,347 | 12.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $4,104 | $834.65 | 20.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 59 | 59 | $56,758 | $12,090 | 21.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 64 | 64 | $43,520 | $11,862 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 97 | 97 | $30,555 | $7,452 | 24.4% |
| 46260 | Removal of multiple hemorrhoid groups | Facility | 2022 | 14 | 14 | $20,202 | $5,584 | 27.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 22 | 22 | $14,960 | $4,119 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 60 | $12,600 | $3,898 | 30.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $12,240 | $2,196 | 17.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $12,305 | $1,610 | 13.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 34 | 37 | $4,662 | $1,428 | 30.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 13 | 13 | $2,808 | $747.00 | 26.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 69 | 69 | $66,378 | $14,344 | 21.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 66 | 66 | $44,880 | $12,655 | 28.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 87 | 87 | $27,405 | $6,935 | 25.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 102 | $21,420 | $6,393 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 71 | $22,010 | $5,744 | 26.1% |
| 46260 | Removal of multiple internal and external hemorrhoid groups | Facility | 2021 | 13 | 13 | $18,759 | $5,119 | 27.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $14,973 | $3,587 | 24.0% |
About Frank Hodnette, MD FACS
Frank Hodnette, MD FACS is a Colon & Rectal Surgery healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407840598.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frank Hodnette, MD FACS has received a total of $1,762 in payments from pharmaceutical and medical device companies, with $103.42 received in 2024. These payments were reported across 48 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,693).
As a Medicare-enrolled provider, Hodnette has provided services to 1,737 Medicare beneficiaries, totaling 1,813 services with total Medicare billing of $212,310. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Colon & Rectal Surgery
- Location Pensacola, FL
- Active Since 09/06/2005
- Last Updated 11/04/2016
- Taxonomy Code 208C00000X
- Entity Type Individual
- NPI Number 1407840598
Products in Payments
- BRIDION (Drug) $410.38
- Ovitex (Device) $221.08
- STRATTICE (Device) $220.60
- ENTEREG (Drug) $210.83
- OFIRMEV (Drug) $201.28
- PICO (Device) $74.55
- SUPREP BOWEL PREP (Drug) $53.32
- OviTex 2S (Device) $47.39
- HEMOBLAST BELLOWS (Device) $34.78
- CLENPIQ (Drug) $27.59
- SEPRAFILM (Device) $27.57
- Stravix (Biological) $21.53
- PREVENA (Device) $21.25
- PREVENA RESTOR BELLA-FORM (Device) $19.69
- PICO7 (Device) $18.63
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) $17.18
- Axonics (Device) $16.72
- Kcentra (Biological) $15.16
- 4-K (Device) $12.48
- PROGEL (Device) $11.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.